Deborah Heart and Lung Center Successfully Performs First Pulse Field Ablation (PFA) Procedure

Browns Mills, NJ - Deborah Heart and Lung Center successfully performed its first Pulse Field Ablation (PFA) procedure using the Medtronic PulseSelect™ system, marking a significant advancement in the hospital's treatment offerings for atrial fibrillation (AFib) - one of the most common and potentially serious heart rhythm disorders.

AFib affects more than 60 million people worldwide and occurs when the upper chambers of the heart beat irregularly. This irregular rhythm disrupts normal blood flow, increasing the risk of stroke, heart failure and other serious complications if left untreated. Deborah's adoption of the PulseSelect system offers new hope to patients seeking effective, minimally invasive treatment options for AFib.

Cardiac electrophysiologist Pedram Kazemian, MD, (fourth from the left) and Deborah Heart and Lung Center's electrophysiology team members gather after completing one of Deborah's first PFA procedures.

The PulseSelect PFA system delivers pulsed electric fields through a specialized catheter to disrupt the abnormal electrical signals that cause AFib. Unlike traditional thermal ablation methods-which use heat (radiofrequency) or cold (cryoablation)-Pulse Field Ablation is non-thermal, and designed to selectively target cardiac tissue while sparing surrounding structures, potentially reducing the risk of complications and enabling quicker recovery.

"We are thrilled to offer this new therapy to our patients," said cardiac electrophysiologist Raffaele Corbisiero, MD, Deborah Heart and Lung Center. "Pulse Field Ablation represents a next-generation approach in arrhythmia care-one that may have specific benefits for our patients. The successful outcome of our first case is a strong step forward for our electrophysiology program and for the people we serve."

Deborah worked in partnership with Medtronic, a global leader in medical technology, to integrate this innovative therapy into its cardiovascular care program.

Cardiac electrophysiologist Raffaele Corbisiero, MD, (fifth from the left) and Deborah Heart and Lung Center's electrophysiology team members gather after completing one of the Deborah's first PFA procedures.

About Deborah Heart and Lung Center
Deborah Heart and Lung Center in Browns Mills, New Jersey, is a teaching hospital in the prevention, diagnosis, research and treatment of heart, lung and vascular diseases. Founded in 1922, Deborah has treated more than 2.3 million hearts from every corner of the United States and 87 countries. From performing the first adult and pediatric open-heart surgeries in New Jersey, to one of the highest-volume left-ventricular assist device (LVAD) implant programs in the nation, Deborah is consistently recognized as a leader overall and in patient care from the Centers for Medicare and Medicaid Services (CMS). It is ranked among the top hospitals in New Jersey for patient satisfaction; holds a top-tier Society of Thoracic Surgeons rating which places Deborah among the best cardiac surgery programs in North America; and is rated High Performing in five specialties, Heart Attack, Heart Bypass Surgery, Heart Failure, COPD and TAVR by U.S. News & World Report. Deborah is an Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute.